EP3582801A4 - ADDITIVE COMPOUNDS FOR PROTEIN PROCESSING - Google Patents

ADDITIVE COMPOUNDS FOR PROTEIN PROCESSING Download PDF

Info

Publication number: EP3582801A4
Authority: EP; European Patent Office
Prior art keywords: protein processing; additive compounds; additive; compounds; protein
Prior art date: 2017-02-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP18754459.8A

Other languages

German (de)

French (fr)

Other versions

EP3582801A1 (en

Inventor

David S. Soane

Philip Wuthrich

Robert P. Mahoney

Mark Moody

Daniel G. GREENE

Neil L. Schauer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Comera Life Sciences Inc

Original Assignee

Reform Biologics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-16

Filing date

2018-02-14

Publication date

2020-12-23

2018-02-14 Application filed by Reform Biologics Inc filed Critical Reform Biologics Inc

2019-12-25 Publication of EP3582801A1 publication Critical patent/EP3582801A1/en

2020-12-23 Publication of EP3582801A4 publication Critical patent/EP3582801A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Mycology (AREA)
Veterinary Medicine (AREA)
Water Supply & Treatment (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP18754459.8A 2017-02-16 2018-02-14 ADDITIVE COMPOUNDS FOR PROTEIN PROCESSING Withdrawn EP3582801A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201762459893P	2017-02-16	2017-02-16
PCT/US2018/018123 WO2018152165A1 (en)	2017-02-16	2018-02-14	Excipient compounds for protein processing

Publications (2)

Publication Number	Publication Date
EP3582801A1 EP3582801A1 (en)	2019-12-25
EP3582801A4 true EP3582801A4 (en)	2020-12-23

Family

ID=63170449

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18754459.8A Withdrawn EP3582801A4 (en)	2017-02-16	2018-02-14	ADDITIVE COMPOUNDS FOR PROTEIN PROCESSING

Country Status (5)

Country	Link
EP (1)	EP3582801A4 (en)
JP (1)	JP2020507593A (en)
KR (1)	KR102572453B1 (en)
CA (1)	CA3053909A1 (en)
WO (1)	WO2018152165A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10478498B2 (en)	2014-06-20	2019-11-19	Reform Biologics, Llc	Excipient compounds for biopolymer formulations
WO2015196091A1 (en)	2014-06-20	2015-12-23	Reform Biologics, Llc	Viscosity-reducing excipient compounds for protein formulations
CN112040931A (en) *	2018-03-07	2020-12-04	改进生物制品有限责任公司	Excipient Compounds for Protein Formulations
KR20210096633A (en) *	2018-11-29	2021-08-05	리폼 바이오로직스, 엘엘씨	Excipient compounds for protein processing
TWI871300B (en) *	2019-01-28	2025-02-01	美商安進公司	A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
WO2021064079A1 (en) *	2019-10-04	2021-04-08	Merck Patent Gmbh	Purification of proteins and viral inactivation
CN113621360A (en) *	2020-05-06	2021-11-09	中国石油化工股份有限公司	Thick oil viscosity reducer and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5710311B2 (en) *	2011-02-18	2015-04-30	株式会社日立製作所	Addition medium addition control method and cell culture apparatus using the method
AU2012328524B2 (en) *	2011-10-28	2017-05-18	Excelse Bio, Inc.	Protein formulations containing amino acids
EP2682168A1 (en) *	2012-07-02	2014-01-08	Millipore Corporation	Purification of biological molecules
IL312865B2 (en) *	2013-09-11	2025-06-01	Eagle Biologics Inc	Liquid protein formulations containing viscosity-reducing agents
WO2015196091A1 (en) *	2014-06-20	2015-12-23	Reform Biologics, Llc	Viscosity-reducing excipient compounds for protein formulations
MX391067B (en) *	2014-10-01	2025-03-21	Eagle Biologics Inc	FORMULATIONS OF POLYSACCHARIDES AND NUCLEIC ACID CONTAINING VISCOSITY REDUCING AGENTS.

2018
- 2018-02-14 KR KR1020197026671A patent/KR102572453B1/en active Active
- 2018-02-14 JP JP2019543842A patent/JP2020507593A/en active Pending
- 2018-02-14 WO PCT/US2018/018123 patent/WO2018152165A1/en not_active Ceased
- 2018-02-14 EP EP18754459.8A patent/EP3582801A4/en not_active Withdrawn
- 2018-02-14 CA CA3053909A patent/CA3053909A1/en active Pending

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
JP2020507593A (en)	2020-03-12
EP3582801A1 (en)	2019-12-25
WO2018152165A1 (en)	2018-08-23
CA3053909A1 (en)	2018-08-23
KR102572453B1 (en)	2023-08-29
KR20190117631A (en)	2019-10-16

Publication	Publication Date	Title
IL257798A (en)	2018-06-28	Antibodies against lag-3
EP3589662A4 (en)	2020-12-30	INDUCTIBLE MONOVALENT ANTIGBINDING PROTEIN
IL254516B (en)	2021-10-31	cd137-specific proteins
EP3454862A4 (en)	2020-02-12	SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION
DK3313876T3 (en)	2025-04-22	MULTISPECIFIC ANTIGEN-BINDING PROTEINS
EP3268324C0 (en)	2023-06-07	PROCEDURE FOR DUST CONTROL
DK3197453T3 (en)	2022-11-21	CHIMERIC PROTEIN
DK3160994T3 (en)	2025-05-05	MULTISPECIFIC ANTIGEN-BINDING PROTEINS
FI20155081A7 (en)	2016-08-07	Method for processing lignin-based material
DK3443071T3 (en)	2022-01-31	HIRELY UNKNOWN BACTERIAL SPECIES
ZA201708041B (en)	2020-07-29	Novel proteins specific for lag-3
LT3298027T (en)	2021-08-10	ANTHELM DEPSIPEPTIDE COMPOUNDS
EP3582801A4 (en)	2020-12-23	ADDITIVE COMPOUNDS FOR PROTEIN PROCESSING
EP3567030A4 (en)	2020-08-12	CHINAZOLINE COMPOUND FOR EGFR INHIBITION
EP3743517A4 (en)	2021-10-13	SEQUENCING ADDITIVE
IL263342A (en)	2018-12-31	Method for stabilizing proteins
NO343600B1 (en)	2019-04-08	FARMING FARMING
DK3416974T3 (en)	2020-09-07	Protein purification
EP3622508C0 (en)	2025-04-23	Stereo parameters for stereo decoding
EP3391577C0 (en)	2023-08-23	REFERENCE SIGNALS FOR ESTIMATING MIXED INTERFERENCE
DK3702450T3 (en)	2024-07-15	PROTEIN
DK3532170T3 (en)	2022-03-07	AEROSOLSPRAY CONTAINING VIVABLE BACTERIAL SPECIES
HUE047606T2 (en)	2020-05-28	Hydration for animals
EP3555092A4 (en)	2020-05-13	PROTEIN KINASE INHIBITORS
HUE056509T2 (en)	2022-02-28	Compounds for huntingtin protein imaging

Legal Events

Date	Code	Title	Description
2018-08-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-11-22	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-11-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-12-25	17P	Request for examination filed	Effective date: 20190905
2019-12-25	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-12-25	AX	Request for extension of the european patent	Extension state: BA ME
2020-05-20	DAV	Request for validation of the european patent (deleted)
2020-05-20	DAX	Request for extension of the european patent (deleted)
2020-11-16	REG	Reference to a national code	Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0038160000 Ipc: C07K0001340000
2020-12-23	A4	Supplementary search report drawn up and despatched	Effective date: 20201120
2020-12-23	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 16/00 20060101ALI20201116BHEP Ipc: A61K 39/395 20060101ALI20201116BHEP Ipc: C07K 1/22 20060101ALI20201116BHEP Ipc: A61K 38/16 20060101ALI20201116BHEP Ipc: C07K 1/34 20060101AFI20201116BHEP
2021-09-01	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: REFORM BIOLOGICS, INC.
2022-04-20	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: COMERA LIFE SCIENCES, INC.
2023-06-21	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230516
2023-09-08	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-10-11	17Q	First examination report despatched	Effective date: 20230912
2024-12-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2025-01-22	18D	Application deemed to be withdrawn	Effective date: 20240903